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Abstract: The current study presents an analysis of main lipid fractions and expression of apolipoprotein A-IV (apoA-IV) of the blood
plasma of calves during the first week of life, before and after administration of a milk replacer with additional quantity of lactose. The
experiment was performed on 7 male Polish-Friesian calves, var. Black-and-White. Blood samples were collected before the morning
feeding from the 6th to 8th day of life. In the evening on the 6th day of the experiment and in the morning on the 7th day of the
experiment, monohydrate lactose in an amount of 2 g per 1 kg of body weight was added to the milk replacer. In all tested calves, after
the administration of the additional quantity of lactose, there was a significant increase observed in expression of apoA-IV in the blood
plasma. At the same time, no significant differences in the concentrations of triglycerides, total cholesterol, and low-density lipoprotein
cholesterol were recorded, both before and after the administration of an additional dose of lactose. A gradual low increase observed in
the plasma high-density lipoprotein cholesterol of calves allows us to conclude that the increase of this lipid fraction after the supply of
an additional lactose is associated with elevated expression of plasma apoA-IV.
Key words: Newborn calves, dietary lactose, lipids, apolipoprotein A-IV

1. Introduction
The greatest economic losses in large-scale cattle breeding
occur while rearing the calves. According to statistical
data from a number of countries, from 12.5% up to 30%
of the animals die during this period (1). Environmental
and dietary factors should be listed among many reasons
of high neonatal mortality of calves. Poor farm hygienic
conditions and improper feeding of young animals
significantly contribute to an increase in the incidence of
diarrhea and pneumonia, which are considered the main
causes of deaths of calves in the first 3 weeks of life (2).
The method of feeding in large-scale breeding prevents
individual treatment, and thus the feeds, including milk
replacers, should meet the highest standards. In recent
years, interest in improving nutrition has greatly increased,
with special emphasis on precise ration balancing at the
level of basic ingredients as well as the use of different
kinds of feed additives. Modern nutrition of young animals
and monitoring of their health status can provide further
satisfactory production and economic effects.
One of the most important elements of newborn calves’
adaptation to extrauterine life is the ability of self-feeding
* Correspondence: katarzyna.michalek@zut.edu.pl

and changes in the metabolism, including replacing the
main energy source, which in utero was carbohydrates,
to fatty acids, in which colostrum is particularly enriched
(3). Therefore, knowledge and monitoring of selected
indicators of lipid metabolism seem to be important in
assessing the health status of calves. Apolipoproteins (apo),
a class of polypeptides present on the surface of the plasma
lipoproteins, play an important role in lipid metabolism and
transport (4). Apolipoproteins differ in terms of structure
and function, and thus they are divided into a number of
classes ranging from apoA to apoJ. These main classes are
divided into subclasses, among which apoA-I, apoA-II,
apoA-IV, apoB-48, apoB-100, apoC-I, apoC-II, and apoCIII should be listed (5). Of particular interest is apoAIV, due to its wide biological roles in lipid metabolism.
Since the discovery of this apolipoprotein in 1974, it has
been attributed with various important functions (6).
Numerous studies suggested that apoA-IV participates
in several steps of the reverse cholesterol transport
pathway, which removes and transports cholesterol from
peripheral cells to the liver or steroid organs (7). ApoAIV is necessary for effective activation of the enzyme
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lecithin cholesterol acyltransferase (8,9). ApoA-IV also
modulates the activation of lipoprotein lipase and the
cholesteryl ester transfer protein, which mediates transfer
of cholesteryl esters from high-density lipoprotein (HDL)
to low-density lipoprotein (LDL) (10,11). Moreover, this
apolipoprotein can affect the regulation of gastric motility
and gastric acid secretion (12). ApoA-IV also exerts an
antiatherosclerotic and antioxidant effect (13,14). ApoAIV in mammals is synthesized mainly in the enterocytes of
the small intestine and its plasma level increase is observed
after ingestion of a fatty meal (15). According to Stan et al.
(16), one of the factors that may increase the expression
of apoA-IV in plasma is the spectrum of carbohydrates in
the diet, such as glucose, fructose, or lactose. Considering
these facts, we conducted a study aimed at determining
whether after the administration of milk replacer to calves
with an additional quantity of lactose the expression of
plasma apoA-IV would be increased. Furthermore, in
order to assess whether any changes in the expression
of ApoA-IV would be reflected in changes in the plasma
concentration of the major lipid fractions, we measured the
concentrations of total cholesterol (TC), HDL cholesterol
(HDLC), triglycerides (TG), and LDL cholesterol (LDLC)
both before and after the administration of an additional
dose of lactose with milk replacer formulation.
2. Materials and methods
2.1. Experimental animals
The experiment was carried out on seven Polish-Holstein
Friesian male calves, var. Black-and-White. They were
fed colostrum until 3 days of age at the dairy farm,
then transported to the Faculty of Biotechnology and
Animal Husbandry at the West Pomeranian University
of Technology in Szczecin (Poland) at 3 days of age.
The animals were held in single pens and were fed with
commercial milk replacer Mlekovit Imupro, manufactured
by Polmass, Poland. The milk replacer contained 23%
crude protein, 16% crude fat, 0.1% crude fiber, 45% lactose,
7.5% crude ash, 1.7% lysine, 0.42% methionine 0.9%
calcium, and 0.7% phosphorus. The calves were fed milk
replacer at 10% of their body weight twice a day. During
the experiment the calves did not have access to water.
Blood samples were collected before the morning feeding
from the 6th to 8th day of life. In the morning of the 6th
day of the experiment and in the evening of the 7th day of
the experiment, monohydrate lactose (Pharma Cosmetic)
in the amount of 2 g per 1 kg of body weight was added
to the milk replacer. The use and handing of animals for
this experiment was approved by the Local Commission
of Ethics for the Care and Use of Laboratory Animals (No.
3/2010 of 14.01.2010).
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2.2. SDS-PAGE and western blot
Expression of apoA-IV in the blood plasma was measured
using the western blot technique. First, in the blood plasma,
the total protein concentration was determined using the
Bradford method (Protein Assay Dye Reagent Concentrate,
Bio-Rad). The samples were diluted in SDS buffer, which
contained a final concentration of 62 mM Tris, 0.1 M SDS,
8.7% glycerol, 0.09 mM bromophenol blue, and 355 mM
2-mercaptoethanol. The samples, warmed to 37 °C, were
loaded on 12% polyacrylamide gels (10 µg denatured
protein dissolved in SDS buffer per sample well) and run
for 120 min at 110 V. The proteins of studied gels were then
electrotransferred (10 V, 15 min) to PVDF membranes.
The membranes were blocked with 5% nonfat milk in
PBS-T (80 mM Na2HPO4, 20 mM NaH2PO4, 100 mM
NaCl, and 0.1% Tween 20, pH 7.5) for 1 h and incubated
overnight at 4 °C with rabbit polyclonal antibodies
anti-apoA-IV NBP 1-86164 (Novus Biologicals) diluted
1:400, followed by incubation with secondary antirabbit
(STAR 124P AbD Serotec) horseradish peroxidaseconjugated antibodies. The labeling was visualized by an
enhanced chemiluminescence (ECL Plus) system and
exposure to a CCD camera (Versadoc 4000MP, Bio-Rad).
Optical density (OD) results obtained by densitometer
are presented as bands, evaluated by the use of Quantity
One software. For apoA-IV the OD values of 42-kDa
bands were determined and use to estimate and compare
expression of this protein in the blood plasma samples.
2.3. Analyses of lipid concentrations in blood plasma
The concentrations of TC, HDLC, and TG were
determined spectrophotometrically using colorimetric
test kits (Biomaxima) according to the manufacturer’s
specifications. The concentration of LDLC was calculated
on the basis of the Friedewald formula (LDL = TC – HDL
– [TG/2.2]) (17).
2.4. Statistics
Mean values and standard deviations were calculated. The
resulting data were analyzed by ANOVA with repeated
measurements and the Duncan multiple range post
hoc test (Statistica 10.0) in order to test significance of
differences.
3. Results
The results for the identification and analysis of the
expression of apoA-IV in the blood plasma of calves tested
are shown in the Figure. Western blot of blood plasma
samples of all the tested calves revealed strong bands with
a mass of 42 kDa. Based on the analysis of average OD
values of these bands, it was found that before lactose
addition to milk replacer, the average OD of apoA-IV in
the blood plasma was 2861.85 ± 355.11. After the first
administration of milk replacer with lactose, apoA-IV
expression was 3058.00 ± 318.29. After the second dose of
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Figure. Expression of apoA-IV in the blood plasma of calves
during their first week of life before and after the administration
of milk replacer supplemented with lactose. The same capital
letters are used to show significant differences.

lactose, a statistically significant increase in the expression
of apoA-IV was recorded (P < 0.0001). The average OD
of this apolipoprotein after two additional doses of lactose
was 5731.18 ± 637.72.
The average values of the concentration of individual
lipid fractions in the plasma of calves obtained in the
experiments are shown in the Table. The concentrations
of TC and TG, both before and after two administrations
of lactose to the milk replacer, were relatively stable and
averaged 0.68 mmol/L and 2.11 mmol/L, respectively.
After the supply of milk replacer containing lactose, a
slight increase was found in HDLC and a slight decrease
in LDLC in the blood plasma of calves. However, these
changes were not statistically significant.
4. Discussion
It is known that in mammals during intestinal fat
absorption the synthesis, secretion, and plasma levels
of apoA-IV are markedly increased (16,18). It was

demonstrated in humans, rats, pigs, and calves that the
expression of apoA-IV is low directly after birth and
increases during the first days of life (19–23). Many authors
observed increased expression of this apolipoprotein in
the neonatal period, which was associated with elevated
intestinal lipid absorption in that period caused by a high
fat intake with milk and energy needs (16). In neonatal
rats, the expression of apoA-IV gradually increases and
reaches values typical for adults after 14 days of life (22).
In addition to lipids, other dietary factors have also been
identified, capable of stimulating apoA-IV gene expression
or plasma concentration. According to Nunez et al. (24),
in preterm newborn infants, dietary nucleotides known
to promote intestinal growth and maturation are likely to
cause an increase in apoA-IV in plasma and elevate the
activity of lecithin cholesterol acyl transferase. Sato et al.
(25) found in rat pups that a diet composed of casein and
lactose increased intestinal apoA-IV levels, but without
alterations of its plasma concentration. In turn, Stan et al.
(16) reported that carbohydrates, including lactose, caused
a rapid rise in serum apoA-IV. In adult rats after the supply
of a diet rich in sucrose, an increase was found in cellular
and nuclear apoA-IV mRNA levels in the liver. However,
there was no simultaneous increase in the intestinal mRNA
level and plasma concentration of apoA-IV (26,27). The
results of the present experiment may indicate that the
double administration of additional quantities of lactose
with milk replacer resulted in a statistically significant
increase in the expression of plasma apoA-IV in the calves
analyzed. Thus, the results obtained appear to confirm
the findings of the aforementioned authors, who reported
that apart from the fat intake, carbohydrates, including
lactose and its breakdown products, such as glucose and
galactose in the diet, can also increase the synthesis and
secretion of intestinal apoA-IV, which is reflected in the
observed increase of this apolipoprotein in blood plasma.
The explanation of this process, however, requires further
and more detailed research.
In comparison to monogastric animals, ruminants,
including cattle, have a characteristic plasma lipid profile.

Table. The concentration of triglycerides, total cholesterol, and HDL and LDL cholesterol in the blood
plasma of calves during their first week of life before and after the administration of milk replacer
supplemented with lactose.

Parameter

Before lactose
addition

After lactose addition
1st dose

2nd dose

Triglycerides (mmol/L)

0.72 ± 0.38

0.69 ± 0.45

0.63 ± 0.16

Total cholesterol (mmol/L)

2.04 ± 0.27

2.09 ± 0.56

2.21 ± 0.55

HDL cholesterol (mmol/L)

1.05 ± 0.48

1.19 ± 0.43

1.23 ± 0.15

LDL cholesterol (mmol/L)

0.61 ± 0.32

0.55 ± 0.12

0.67 ± 0.23
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Fermentation of the rumen content, associated with
intensive lipid hydrolysis and biodegradation of the bulk
of fatty acids by bacteria and protozoa, causes the fatty
acids absorbed from the small intestine to be primarily
of the saturated type. The continuous flow of the chyme
to the small intestine with a high content of unsaturated
fatty acids promotes the formation of mainly the very-lowdensity lipoprotein (VLDL) fraction in the enterocytes.
Under natural conditions, approximately 73% of lipids
present in the lymph flowing from the gastrointestinal tract
are of the VLDL fraction, and only about 23% are of the
chylomicron fraction (3,28). Cattle and other ruminants
are characterized by a low plasma concentration of TG and
TG-rich lipoproteins (29,30). In contrast to monogastric
animals, the major fraction of plasma lipoproteins in
ruminants is HDL, which in adult cattle can constitute up
to 80% of all lipoproteins (31). Low concentration of the
VLDL fraction in the blood plasma of ruminants is related
to its low biosynthesis and secretion in the liver (3,32).
Moreover, unlike monogastric animals, TG formed by
the esterification of free fatty acids in ruminants does not
undergo hydrolysis in the hepatocytes, which together with
a low capacity of VLDL synthesis promotes accumulation
of TG, which can lead to so-called fatty liver (3). In
newborn calves up to 1–2 months of age, the reticulorumen
is poorly developed, and hence the lack in this period
of fermentation processes and numerous microbial
modifications of the chemical structure of dietary lipids.
Therefore, calves, often referred to as preruminants, can
be functionally considered monogastric (28). However,
serum lipoproteins of newborns calves are characterized
by and compared with those of adult animals, while the
quantitative composition in the perinatal period is closely
associated with dietary intake.
In the present study, TG concentration in the first
week of life of the calves was relatively stable and ranged
from 0.63 to 0.72 mmol/L; double application of a milk
replacer to calves with the addition of lactose did not
result in significant changes in the concentration of plasma
TG. Similar results were obtained by Herosimczyk et al.
(19). Those authors found that the level of plasma TG in
7-day-old calves amounted on average to 0.62 mmol/L.
Jankowiak et al. (3) indicated that the concentration of TG
in the blood plasma of calves from day 5 to 8 of age ranged
from 0.47 to 0.68 mmol/L. The main factor conditioning
the relatively high, compared to adults, TG concentration
in the first days of life is the supply of high fat content in
the colostrum and milk. In calves in which the supply of
colostrum was restricted directly after birth, TG increase
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was not observed even up to 7 days of age (33). The average
concentration of total cholesterol in the animals studied
was lower than that observed by other authors in calves fed
mother’s milk (19). Low TC concentration was probably
due to the fact that calves from 4 days of age were fed
only milk replacer formulation. According to Hammon
and Blum (33), a significant impact on the concentration
of cholesterol in the blood plasma is had by the total
contents of lipids and unsaturated and saturated fatty
acids in the diet, and the administration of milk replacers
to calves during the first days of life significantly reduces
the increase in plasma TC level. As compared to calves
fed mother’s milk, the current experiments also found
lower HDLC concentration values. However, the LDLC
concentration was similar (3,19). Lower HDLC fraction
is probably associated with a lower level of cholesterol
in the studied calves, because, as mentioned earlier, the
vast majority of ruminant blood plasma TC is located
in HDL. In the experimental calves, a slight increase in
HDLC was observed after the supply of additional doses
of lactose. The elevated expression of apoA-IV in plasma
accompanying these changes allowed us to assume that
an increase in the HDLC fraction was associated with a
rise of the plasma concentration of this apolipoprotein.
It is known that apoA-IV circulates in the blood plasma
predominantly in a form not bound with lipoproteins or
bound with the mentioned HDL fraction (34).
In summary, the present research found that in the
first week of life, after the administration to calves of
an additional quantity of lactose with milk replacer
formulation, there was a significant increase observed in
expression of apoA-IV in the blood plasma. At the same
time, no significant differences in the concentrations of TG,
TC, and LDLC were recorded, both before and after the
administration of an additional dose of lactose. A gradual
low increase observed in the plasma HDLC of calves
allows us to conclude that the increase of this lipid fraction
after the supply of an additional lactose is associated with
elevated expression of plasma apoA-IV. The present study
demonstrated that the use of a milk replacer supplemented
with lactose, in addition to increasing the levels of apoAIV, did not seem to affect the changes in individual lipid
fractions in the blood plasma of calves during the first
week of life
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